Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels

被引：36

作者：

Arentz G. ^{[1
,2
]}

Chataway T. ^{[3
]}

Price T.J. ^{[1
,4
]}

Izwan Z. ^{[1
,2
]}

Hardi G. ^{[1
,2
]}

Cummins A.G. ^{[4
,5
]}

Hardingham J.E. ^{[1
,2
]}

机构：

[1] Department of Haematology-Oncology, Queen Elizabeth Hospital, Woodville

[2] Department of Physiology, University of Adelaide

[3] Department of Physiology, Flinders University, Bedford Park

[4] Department of Medicine, University of Adelaide

[5] Department of Gastroenterology and Hepatology, Queen Elizabeth Hospital, Woodville

来源：

Clinical Proteomics | 2011年 / 8卷 / 1期

关键词：

2D DIGE; angiogenesis; biomarker; Colorectal cancer; desmin; pericyte;

D O I：

10.1186/1559-0275-8-16

中图分类号：

学科分类号：

摘要：

Introduction. Biomarkers that improve stratification of colorectal cancer patients for adjuvant therapy versus resection alone, or that are predictive of response to therapeutic agents, have the potential to greatly improve patient selection for such therapies. The aim was to determine proteins differentially expressed within the malignant epithelial glands and closely associated stromal elements compared to matched normal mucosa, and to characterise the over-expression of one such protein as a potential biomarker. Methods. Protein from laser microdissected tumor and normal mucosa was analysed by two dimensional difference gel electrophoresis (2D DIGE) and mass spectrometry to determine differentially over expressed tumor proteins. Tumor over-expression of one such protein, desmin, was quantified using immunofluorescence staining in a larger cohort. Dual staining for desmin and vimentin, or desmin and von Willebrand factor, was performed to determine the cell type of interest. Results: Desmin expression was significantly increased between stage I and III tumors, (P < 0.0001), and stage II and III tumors, (P < 0.0001). Strong focal desmin expression was found in stroma directly adjacent to carcinomatous glands and microvessels. These cells showed co-localisation of desmin and vimentin in close association with cells expressing VWF, indicating they were pericytes. Significantly higher levels of desmin-positive pericytes were observed in late stage tumors, consistent with increased angiogenesis. Conclusion: Pericyte coverage of vasculature is a marker of vessel maturation, hence desmin expression may have use as a marker for microvessel maturation. Clinical trials will be needed to determine its use in identifying tumors that will be less responsive to anti-angiogenic therapy. © 2011 Arentz et al; licensee BioMed Central Ltd.

引用

共 40 条

[1]

O'Connell J.B., Maggard M.A., Ko C.Y., Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging, Journal of the National Cancer Institute, 96, 19, pp. 1420-1425, (2004)

[2]

Tsavellas G., Patel H., Allen-Mersh T.G., Detection and clinical significance of occult tumour cells in colorectal cancer, British Journal of Surgery, 88, 10, pp. 1307-1320, (2001)

[3]

Lloyd J.M., McIver C.M., Stephenson S.-A., Hewett P.J., Rieger N., Hardingham J.E., Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells, Clinical Cancer Research, 12, 2, pp. 417-423, (2006)

[4]

Hsu J.Y., Wakelee H.A., Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor, BioDrugs, 23, pp. 289-304, (2009)

[5]

De Wever O., Mareel M., Role of tissue stroma in cancer cell invasion, Journal of Pathology, 200, 4, pp. 429-447, (2003)

[6]

Brown L.F., Guidi A.J., Schnitt S.J., Van De Water L., Iruela-Arispe M.L., Yeo T.-K., Tognazzi K., Dvorak H.F., Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast, Clinical Cancer Research, 5, 5, pp. 1041-1056, (1999)

[7]

Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R., Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium, Cancer Research, 59, 19, pp. 5002-5011, (1999)

[8]

Karagiannis G.S., Pavlou M.P., Diamandis E.P., Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology, Mol Oncol, 4, pp. 496-510, (2010)

[9]

Sugiyama Y., Farrow B., Murillo C., Li J., Watanabe H., Sugiyama K., Evers B.M., Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues, Gastroenterology, 128, 2, pp. 480-486, (2005)

[10]

Lawrie L.C., Curran S., McLeod H.L., Fothergill J.E., Murray G.I., Application of laser capture microdissection and proteomics in colon cancer, Journal of Clinical Pathology - Molecular Pathology, 54, 4, pp. 253-258, (2001)

← 1 2 3 4 →